Olema Pharmaceuticals

OLMA52

$13.67arrow_drop_up0.51%$0.07

OLMA52

$13.67

arrow_drop_up0.51%$0.07

Performance History

Key Stats
Open	$13.53
Prev. Close	$13.60
EPS	-2.04
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	13.41	13.80
52 Week Range	8.51	17.79

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-2.04

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Olema Pharmaceuticals (OLMA)

Olema Pharmaceuticals Inc (OLMA) is a leading biopharmaceutical company that specializes in the development and commercialization of innovative cancer therapies. With a strong focus on precision medicine, OLMA aims to provide targeted treatments that address specific genetic mutations and biomarkers associated with various types of cancer. The company's portfolio includes several promising drug candidates that have shown great potential in preclinical and clinical trials.

One of OLMA's flagship products is its novel drug candidate, which has been designed to inhibit the growth of cancer cells by targeting a specific protein pathway that is often dysregulated in cancer. Preclinical studies have demonstrated that this drug candidate effectively suppresses tumor growth and improves overall survival rates in animal models. OLMA is currently in the process of conducting phase I clinical trials to evaluate the safety and efficacy of this drug candidate in humans.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Sean P. Bohen M.D., Ph.D.
Headquarters: San Francisco
Employees: 67
Exchange: NASDAQ

Keep an eye on Olema Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Olema Pharmaceuticals 's (OLMA) price per share?

The current price per share for Olema Pharmaceuticals (OLMA) is $13.67. The stock has seen a price change of $0.07 recently, indicating a 0.51% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Olema Pharmaceuticals (OLMA)?

For Olema Pharmaceuticals (OLMA), the 52-week high is $17.79, which is 30.15% from the current price. The 52-week low is $8.51, the current price is 60.63% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Olema Pharmaceuticals (OLMA) a growth stock?

Olema Pharmaceuticals (OLMA) has shown an average price growth of 0.41% over the past three years. It has received a score of 86 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Olema Pharmaceuticals as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Olema Pharmaceuticals (OLMA) stock price performance year to date (YTD)?

As of the latest data, Olema Pharmaceuticals (OLMA) has a year-to-date price change of -0.44%. Over the past month, the stock has experienced a price change of 9.45%. Over the last three months, the change has been 19.7%. Over the past six months, the figure is 18.35%.

help

Is Olema Pharmaceuticals (OLMA) a profitable company?

Olema Pharmaceuticals (OLMA) has a net income of -$96.66M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$104.96M. Furthermore, the EBITDA is -$122.27M.

help

What is the market capitalization of Olema Pharmaceuticals (OLMA)?

Olema Pharmaceuticals (OLMA) has a market capitalization of $702.66M. The average daily trading volume is 448.21K, indicating the stock's liquidity and investor engagement.